Healthpeak Properties (NYSE:DOC) Announces FY 2026 Earnings Guidance

Healthpeak Properties (NYSE:DOC) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided EPS guidance of 1.760-1.780 for the period, compared to the consensus EPS estimate of 1.770.

Healthpeak Properties Price Performance

Shares of NYSE DOC opened at $19.63 on Wednesday. Healthpeak Properties has a fifty-two week low of $15.70 and a fifty-two week high of $22.95. The business has a 50 day moving average price of $19.82 and a two-hundred day moving average price of $19.16. The company has a quick ratio of 3.02, a current ratio of 3.02 and a debt-to-equity ratio of 1.06. The firm has a market cap of $13.53 billion, a PE ratio of 10.70, a price-to-earnings-growth ratio of 2.41 and a beta of 1.01.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Monday, November 2nd. The real estate investment trust reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by ($0.41). Healthpeak Properties had a return on equity of 4.25% and a net margin of 12.32%. The business had revenue of $820.89 million for the quarter, compared to analysts’ expectations of $739.18 million. During the same quarter in the prior year, the firm earned $0.46 earnings per share. Healthpeak Properties’s revenue for the quarter was up 16.3% compared to the same quarter last year. Sell-side analysts expect that Healthpeak Properties will post 1.77 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently declared a monthly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 18th will be given a dividend of $0.1017 per share. The ex-dividend date of this dividend is Friday, December 18th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.2%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 225.93%.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. Royal Bank Of Canada lifted their price target on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, August 10th. Citigroup increased their price objective on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Tuesday, August 11th. Barclays reduced their price objective on shares of Healthpeak Properties from $24.00 to $21.00 and set an “equal weight” rating on the stock in a research note on Tuesday, October 13th. Weiss Ratings lowered shares of Healthpeak Properties from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, September 16th. Finally, UBS Group dropped their target price on shares of Healthpeak Properties from $21.50 to $20.00 and set a “neutral” rating for the company in a research report on Tuesday, October 13th. Four research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Healthpeak Properties currently has an average rating of “Hold” and a consensus target price of $21.47.

More Healthpeak Properties News

Here are the key news stories impacting Healthpeak Properties this week:

• Positive Sentiment: Healthpeak raised its full-year 2026 adjusted FFO guidance to $1.76–$1.78 per share, a range that brackets the $1.77 consensus estimate. Third-quarter adjusted FFO of $0.44 also topped the $0.43 estimate. Healthpeak Q3 results and guidance
• Positive Sentiment: Operating activity was supportive: outpatient medical lease executions totaled 846,000 square feet, while senior housing growth and outpatient leasing helped drive results. Revenue rose 16.3% year over year. Healthpeak’s Q3 FFOA and operating growth
• Neutral Sentiment: Healthpeak is targeting a two- to three-year lease-up for lab properties tied to acquisitions that are about 41% occupied. Longer-term leasing could add income, but occupancy needs time to improve. Healthpeak FFO guidance and lab lease-up plans
• Negative Sentiment: Adjusted FFO declined from $0.46 per share a year earlier, and reported GAAP EPS of $0.02 was well below the cited $0.43 consensus. Coverage also flagged refinancing risk, which may weigh on investor confidence amid ongoing financing needs. Healthpeak stock and refinancing risk

About Healthpeak Properties

Healthpeak Properties, Inc (NYSE:DOC) is a real estate investment trust that owns, operates and develops healthcare-related real estate in the United States. The company primarily serves healthcare providers, research organizations and senior-care operators through a portfolio of specialized properties.

Its main activities include the ownership and leasing of outpatient medical office buildings, life science facilities and senior housing properties. These assets support services such as physician practices, ambulatory care, medical research and senior living.